Epigenetic modulation ofBRCA1andBRCA2gene expression by equol in breast cancer cell lines

Authors:

Abstract
S-Equol is a metabolite resulting from the conversion of daidzein, a soya phyto-oestrogen, by the gut microflora. The potential protective effects of equol in breast cancer are still under debate. Consequently, we investigated the effects of equol on DNA methylation of breast cancer susceptibility genes (BRCA1andBRCA2) and oncosuppressors in breast cancer cell lines (MDA-MB-231 and MCF-7) and in a dystrophic breast cell line (MCF-10a) following exposure toS-equol (2 μm) for 3 weeks. We demonstrated by quantitative analysis of methylated alleles a significant decrease in the methylation of the cytosine phosphate guanine (CpG) islands in the promoters ofBRCA1andBRCA2after theS-equol treatment in MCF-7 and MDA-MB-231 cells and a trend in MCF-10a cells. We also showed thatS-equol increases BRCA1 and BRCA2 protein expression in the nuclei and the cytoplasm in MCF-7, MDA-MB-231 and MCF-10a cell lines by immunohistochemistry. The increase in BRCA1 and BRCA2 proteins was also found after Western blotting in the studied cell lines. In summary, we demonstrated the demethylating effect ofS-equol on the CpG islands inside the promoters ofBRCA1andBRCA2genes, resulting in an increase in the level of expressed oncosuppressors in breast cancer cell lines.

This publication has 59 references indexed in Scilit: